Endocrinology Fax & Paper Form Automation: Accelerating PA Workflows

For endocrinology practices, navigating the complexities of prior authorizations often means confronting a persistent challenge: the need for efficient endocrinology fax & paper form automation.

Many payers still rely on fax or proprietary paper forms for critical prior authorization submissions, particularly for high-cost endocrinology treatments. This manual workflow creates significant administrative overhead, diverts staff from patient care, and introduces delays that impact patient access to essential medications and devices. Klivira transforms these long-tail payer fax workflows into automated, digital processes.

The Persistent Challenge of Manual PA in Endocrinology

Despite advances in electronic prior authorization (ePA), a substantial portion of payer submissions for endocrinology treatments still mandate fax or paper forms. This is particularly true for high-volume categories like GLP-1 agonists, continuous glucose monitors (CGMs), and insulin pumps, where payer-specific criteria and documentation often necessitate manual form completion and submission.

Key Endocrinology PA Categories Requiring Fax & Paper Automation

**GLP-1 Receptor Agonists & Dual GIP/GLP-1 Agonists**: Medications like Ozempic, Mounjaro, and Zepbound often face extensive, payer-specific coverage criteria for T2D and obesity indications, frequently requiring faxed forms.
**Continuous Glucose Monitoring (CGM) Systems**: Devices such as Dexcom G7 and FreeStyle Libre 3/2 require initial PAs and re-authorizations, which many payers still process via fax, with criteria varying by diabetes type.
**Insulin Pumps & Tubeless Systems**: Tandem t:slim X2 and Omnipod 5 often involve detailed documentation of insulin-requiring status and prior MDI trials, channeled through fax or paper submissions.
**Growth Hormone Therapy**: Somatropin biosimilars and other growth hormone treatments frequently require extensive diagnostic documentation, often submitted via traditional channels.
**SGLT2 Inhibitors**: While often less restrictive than GLP-1s, specific indications (e.g., heart failure, CKD) can still trigger fax-based PA requirements.

Automating Data Extraction and Form Population for Endocrinology PAs

Klivira's platform leverages advanced OCR (Optical Character Recognition) and intelligent automation to extract relevant clinical data directly from your EMR. This data, including A1c levels, BMI, prior medication trials, and diagnostic documentation, is then accurately mapped and populated onto payer-specific fax forms, eliminating manual transcription errors and accelerating submission for endocrinology prior authorizations. This process ensures documentation aligns with guidelines like ADA Standards of Care and AACE Clinical Practice Guidelines.

Streamlining Re-authorizations for Chronic Endocrinology Conditions

Many endocrinology patients require ongoing treatment for chronic conditions, leading to periodic re-authorization cycles for devices like CGMs and insulin pumps. These often demand updated adherence documentation and clinical notes. Klivira automates the preparation and submission of these re-authorization forms, ensuring timely renewals and continuity of care for your patients, even when payers insist on faxed submissions.

Integrating Fax Automation into Your Existing Workflows

Klivira seamlessly integrates with your existing EMR system, pulling the necessary clinical data for endocrinology PAs. Our platform then manages the submission process for fax and paper forms, providing a digital audit trail and status tracking for every prior authorization. This approach minimizes disruption to your clinic's operations while maximizing efficiency for even the most challenging long-tail payer fax workflows.

Frequently asked questions

How does Klivira handle the variability of GLP-1 coverage criteria on fax forms?

Klivira's platform is configured to recognize and apply payer-specific coverage criteria for GLP-1 agonists, distinguishing between T2D and obesity indications. It ensures that all required documentation, such as A1c, BMI, and prior medication trials, is accurately extracted from the EMR and populated onto the correct sections of the payer's fax form, aligning with guidelines from bodies like the ADA and AACE.

Can Klivira automate re-authorizations for CGMs and insulin pumps submitted via fax?

Yes, Klivira automates re-authorization workflows for continuous glucose monitors and insulin pumps, even for payers requiring fax submissions. Our system tracks re-authorization cycles and prompts for updated clinical documentation, such as adherence data, which is then automatically populated onto the necessary forms and submitted.

What EMR data does Klivira use to pre-fill endocrinology fax forms?

Klivira extracts a wide range of relevant clinical data from your EMR to pre-fill endocrinology fax forms. This includes patient demographics, diagnoses (e.g., T1D, T2D, obesity), A1c levels, BMI, eGFR, IGF-1 levels, prior medication trials (e.g., metformin), contraindications, and documentation of lifestyle modifications, ensuring comprehensive and accurate submissions.

How does Klivira ensure compliance with ADA/AACE guidelines when automating fax submissions?

Klivira's automation engine is built with an understanding of dominant clinical guidelines such as the ADA Standards of Care and AACE Clinical Practice Guidelines. The platform helps ensure that all required documentation for conditions like T2D, obesity, and diabetes device use is present and correctly formatted on fax submissions, supporting your compliance efforts with payer policies and clinical best practices.

Does Klivira integrate with specialty pharmacies that often receive faxed PAs for endocrinology drugs?

Klivira's platform focuses on automating the prior authorization process with payers. While our primary integration is with EMRs and direct payer channels, the output of our fax automation can be used to streamline communication with specialty pharmacies, ensuring they receive complete and approved prior authorization documentation for fulfillment of endocrinology medications like GLP-1s.